Connect Biopharma Holdings Limited (CNTB) vs RenovoRx, Inc. (RNXT)
A side-by-side comparison of Connect Biopharma Holdings Limited and RenovoRx, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CNTB
Connect Biopharma Holdings Limited
$0.94HealthcareDelayed quote: Oct 6, 2026, 2:20 PM EDT
RNXT
RenovoRx, Inc.
$1.40HealthcareDelayed quote: Oct 6, 2026, 2:15 PM EDT
Total return — CNTB vs RNXT
growth of $100 · dividends reinvested · last 5yCNTB -95.5% (-46.3%/yr)RNXT -79.8% (-27.3%/yr)RNXT compounded faster over this window
CNTB RNXT
CNTB vs RNXT: by the numbers
- •RNXT is the larger company ($63M vs $59M market cap).
- •Both run net losses; RNXT's is the smaller (-621.71% vs -86687.50% net margin).
Metrics side by side
Valuation
| Metric | CNTB | RNXT |
|---|---|---|
| P/S ratio | N/A | 31.81 |
| P/B ratio | 2.20 | 7.00 |
Profitability
| Metric | CNTB | RNXT |
|---|---|---|
| Gross margin | 100.00% | 70.88% |
| Operating margin | -90740.62% | -1113.98% |
| Net margin | -86687.50% | -621.71% |
| ROE | -132.16% | -136.82% |
| ROIC | -136.77% | -139.74% |
Growth (annualized)
| Metric | CNTB | RNXT |
|---|---|---|
| Total return CAGR (5Y) | -47.22% | -23.80% |
Frequently asked
- How have CNTB and RNXT total returns compared?
- Over the past 5 years, CNTB delivered -47.22% and RNXT delivered -23.80% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.